Jay Steingrub to Protein C
This is a "connection" page, showing publications Jay Steingrub has written about Protein C.
Connection Strength
1.234
-
Steingrub JS, Cheatham ML, Woodward B, Wang HT, Effron MB. A prospective, observational study of Xigris Use in the United States (XEUS). J Crit Care. 2010 Dec; 25(4):660.e9-16.
Score: 0.344
-
Lindenauer PK, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis. Crit Care Med. 2010 Apr; 38(4):1101-7.
Score: 0.328
-
Steingrub JS. Steroids and drotrecogin alfa (activated) for severe sepsis. Chest. 2003 Nov; 124(5):2033.
Score: 0.210
-
Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med. 2008 Sep 15; 178(6):618-23.
Score: 0.073
-
Wheeler A, Steingrub J, Schmidt GA, Sanchez P, Jacobi J, Linde-Zwirble W, Bates B, Qualy RL, Woodward B, Zeckel M. A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial. Crit Care Med. 2008 Jan; 36(1):14-23.
Score: 0.070
-
Higgins TL, Steingrub JS, Tereso GJ, Tidswell MA, McGee WT. Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes. J Intensive Care Med. 2005 Nov-Dec; 20(6):339-45.
Score: 0.060
-
Levy H, Small D, Heiselman DE, Riker R, Steingrub J, Chen R, Qualy RL, Darstein C, Mongan E. Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis. Ann Pharmacother. 2005 Feb; 39(2):262-7.
Score: 0.057
-
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 08; 344(10):699-709.
Score: 0.044
-
Agrawal A, Zhuo H, Brady S, Levitt J, Steingrub J, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Matthay MA, Liu KD. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol. 2012 Oct 15; 303(8):L634-9.
Score: 0.024
-
Lagu T, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS, Lindenauer PK. Variation in the care of septic shock: the impact of patient and hospital characteristics. J Crit Care. 2012 Aug; 27(4):329-36.
Score: 0.023